Safety and biomarker effects of candesartan in non-hypertensive adults with prodromal Alzheimer's disease. - Hajjar I; Okafor M; Wan L; Yang Z; Nye JA; Bohsali A; Shaw LM; Levey AI; Lah JJ; Calhoun VD; Moore RH; Goldstein FC (Brain communications, 2022)